Cell-Easy begrüßt Frau Gisele Deblandre, ehemals CSO bei MaSTherCell, als Chief Scientific Officer
03 oct. 2023 04h09 HE
|
CELL-EASY
TOULOUSE, Frankreich, Oct. 03, 2023 (GLOBE NEWSWIRE) -- Cell-Easy, ein auf Zelltherapie spezialisiertes Auftragsentwicklungs- und -fertigungsunternehmen (Contract Development and Manufacturing...
Cell-Easy, CDMO spécialisée en thérapie cellulaire, nomme Mme Gisèle Deblandre au poste de directrice scientifique
03 oct. 2023 04h09 HE
|
CELL-EASY
TOULOUSE, France, 03 oct. 2023 (GLOBE NEWSWIRE) -- Cell-Easy, CDMO (contract development and manufacturing organization) spécialisée en thérapie cellulaire, est fière d'annoncer la nomination de Mme...
Cell-Easy is pleased to welcome Mrs. Gisele Deblandre, formerly CSO at MaSTherCell, as Chief Scientific Officer
28 sept. 2023 08h15 HE
|
CELL-EASY
Cell-Easy, a contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre.